肿瘤栓塞剂市场
市场调查报告书
商品编码
1402224

肿瘤栓塞剂市场

Oncology Embolization Agents Market Snapshot

出版日期: | 出版商: Life Science Intelligence | 英文 10 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

肿瘤栓塞剂用于闭塞病灶和肿瘤中的血管、靶向营养物质、增强标靶药物递送的有效性并诱导细胞死亡。

本报告提供肿瘤栓塞剂市场相关 之详细考察,提供市场概要,以及2022年~2027年的台数与市场预测,竞争情形,主要的活动相关洞察。

目录

  • 2022年~2027年的台数
  • 2022年~2027年的市场预测
  • 主要的竞争企业的竞争情形分析
  • 针对策略企业及新兴企业的主要市场活动相关洞察
简介目录
Product Code: LSI12012023-oncology-embolization-agents-market-snapshot

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.

This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:

  • Unit volumes from 2022 to 2027
  • Market forecasts from 2022 to 2027
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups